Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Breakthrough multiple sclerosis research sheds light on cause of the disease

April 24, 2017 Research and Development, Sales and Marketing multiple sclerosis

Researchers from the Universities of Exeter and Alberta have identified a protein in the brain which they believe could be …
News

Janssen acquires over 90% of Actelion

April 24, 2017 Sales and Marketing Actelion, Janssen

Actelion has revealed that, following the wrap of its $30 billion deal in January, Janssen Holding has acquired 92.51% of …
News

EU recommendation for Sanofi and Regeneron’s arthritis treatment

April 24, 2017 Sales and Marketing Kevzara, NICE, sarilumab

Sanofi and Regeneron are celebrating the news that their treatment Kevzara (sarilumab) has received a positive opinion from the EMA’s …
News

England “really is not a good place” to get cancer, BMS UK General Manager says

April 24, 2017 Medical Communications, Research and Development, Sales and Marketing BMS, NICE, opdivo

Bristol-Myers Squibb’s UK General Manager Ben Hickey has slammed NICE over its assessment criteria and process in recommending access to …
News

Applied DNA Sciences agrees deal for bulk DNA manufacturing

April 21, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Applied DNA sciences, DNA manufacture

In a deal that sounds more like something to come out of a science-fiction novel, Applied DNA Sciences has agreed …
News

FDA restricts administration of strong pain killers to children

April 21, 2017 Medical Communications, Sales and Marketing FDA, opioid

The FDA has announced that it will require medication including codeine and tramadol, two high-strength painkillers, to have its strongest …
News

Top Ten most popular articles on Pharmafile.com this week

April 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Another week has whizzed round again as we race into Spring, and a breadth of stories have piqued the interests …
News

Teva launches competitors to GSK’s Advair inhaler

April 21, 2017 Medical Communications, Sales and Marketing Advair, AirDuo, GSK, Teva, asthma

GSK has been anticipating competition to its Advair for two years and Teva has announced that it will be the …
News

How can big data improve humanity?

April 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data

Alexander Hitchcock and Eleonora Harwich, researchers at UK think tank Reform, discuss the increasing importance of big data in the …
Feature

Alpine Immune Sciences boosts prospects with Nivalis merger

April 20, 2017 Sales and Marketing Alpine Immune Sciences, Nivalis Therapeutics, merger

Alpine Immune Sciences has agreed a deal to merge with Nivalis Therapeutics, in an all-stock deal. The merger sees Alpine …
News

How regulators and NGOs are bringing the threat of fake medicines to light

April 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Fake medicine, counterfeit medicine, fake drugs

If recent world events are anything to go by, there is a growing awareness that anything read on the internet …
Feature

FDA warns of dangers of Hyland’s homeopathic teething tablets as recall is issued

April 18, 2017 Manufacturing and Production, Sales and Marketing FDA, Hyland, recall

After months of FDA warnings, Hyland has finally issued an official voluntary recall of its homeopathic teething tablets, with the …
News

Circassia stumbles with allergy treatments at clinical trial stage, again

April 18, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Circassia

Circassia has slumped at the Phase 2 clinical trial stage again, after its failure with a treatment for those with …
News

Roche’s drug scores expanded FDA indication in advanced bladder cancer

April 18, 2017 Manufacturing and Production, Sales and Marketing Genentech, Roche, tecentriq

Roche’s Genentech has revealed that its immunotherapy drug Tecentriq (atezolizumab) is now enjoying an expanded indication in the US after …
News

‘Smart bandages’ could offer real-time wound feedback

April 18, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Swansea University, smart bandage

The problem with bandages is that often we do not know how well a wound has healed under them until …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026